April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 31, 2025

Microplastics Linked to Cardiovascular Disease

Research reveals significant associations between environmental microplastic pollution and increased rates of hypertension, diabetes, and stroke across U.S. coastal communities, with pollution levels ranking among top predictors for chronic disease prevalence.

Conexiant

March 31, 2025

Clopidogrel Outshines Aspirin After PCI

“In our study, clopidogrel beat aspirin as a lifelong maintenance monotherapy after standard-duration dual antiplatelet therapy."

Conexiant

March 31, 2025

Hormone Therapy Boosts Semaglutide Weight Loss

At 12 months, women on hormone therapy achieved 16% total body weight loss with semaglutide, compared to 12% in those not using hormone therapy, researchers reported.

Conexiant

March 27, 2025

Trends in Spironolactone Prescribing Among Young Women

A cohort study of 38 million insured females aged 12 to 40 years found a marked increase in spironolactone prescriptions, most commonly for acne and other androgen-related conditions.

Conexiant

March 26, 2025

What’s Brewing at Work May Raise Heart Risks

Research identifies high levels of LDL-raising compounds in workplace coffee machine brews, potentially increasing cardiovascular risk for regular consumers.

Conexiant

March 25, 2025

Weight Regain After Bariatric Surgery Not Deadly, Study

"Partial weight regain after substantial weight loss was associated with a less favorable cardiovascular risk profile and an increased incidence of both microvascular and macrovascular diseases."

Conexiant

March 24, 2025

Cannabis Use: Multicenter Study Links to Increased MI, Stroke Risks

Cannabis use associated with over sixfold higher risk of myocardial infarction in otherwise healthy adults, according to new multicenter study.

Conexiant